Description
Tirzepatide (20 mg) is a high-purity lyophilized peptide engineered for cutting-edge research in advanced metabolic optimization and next-generation glycemic control. As a potent dual co-agonist of both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, this compound operates with remarkable efficiency to decelerate gastric emptying, enhance prolonged satiety, and dramatically improve insulin sensitivity.
It stands as the ideal selection for biohacking protocols aimed at suppressing food cravings, elevating basal energy expenditure, accelerating the oxidation of recalcitrant body fat, and achieving comprehensive, sustainable body recomposition.
Reviews
There are no reviews yet.